IRIDEX Retained Earnings (Accumulated Deficit) 2010-2024 | IRIX
IRIDEX retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
IRIDEX Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$-79 |
| 2022 |
$-70 |
| 2021 |
$-62 |
| 2020 |
$-57 |
| 2019 |
$-51 |
| 2018 |
$-42 |
| 2017 |
$-29 |
| 2016 |
$-16 |
| 2015 |
$-4 |
| 2014 |
$-5 |
| 2013 |
$-15 |
| 2012 |
$-17 |
| 2011 |
$-19 |
| 2010 |
$-21 |
| 2009 |
$-24 |
IRIDEX Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-09-30 |
$-87 |
| 2024-06-30 |
$-85 |
| 2024-03-31 |
$-83 |
| 2023-12-31 |
$-79 |
| 2023-09-30 |
$-76 |
| 2023-06-30 |
$-74 |
| 2023-03-31 |
$-72 |
| 2022-12-31 |
$-70 |
| 2022-09-30 |
$-69 |
| 2022-06-30 |
$-67 |
| 2022-03-31 |
$-65 |
| 2021-12-31 |
$-62 |
| 2021-09-30 |
$-60 |
| 2021-06-30 |
$-58 |
| 2021-03-31 |
$-59 |
| 2020-12-31 |
$-57 |
| 2020-09-30 |
$-57 |
| 2020-06-30 |
$-55 |
| 2020-03-31 |
$-52 |
| 2019-12-31 |
$-51 |
| 2019-09-30 |
$-49 |
| 2019-06-30 |
$-47 |
| 2019-03-31 |
$-45 |
| 2018-12-31 |
$-42 |
| 2018-09-30 |
$-39 |
| 2018-06-30 |
$-36 |
| 2018-03-31 |
$-33 |
| 2017-12-31 |
$-29 |
| 2017-09-30 |
$-24 |
| 2017-06-30 |
$-21 |
| 2017-03-31 |
$-18 |
| 2016-12-31 |
$-16 |
| 2016-09-30 |
$-5 |
| 2016-06-30 |
$-5 |
| 2016-03-31 |
$-4 |
| 2015-12-31 |
$-4 |
| 2015-09-30 |
$-5 |
| 2015-06-30 |
$-5 |
| 2015-03-31 |
$-5 |
| 2014-12-31 |
$-5 |
| 2014-09-30 |
$-14 |
| 2014-06-30 |
$-14 |
| 2014-03-31 |
$-14 |
| 2013-12-31 |
$-15 |
| 2013-09-30 |
$-15 |
| 2013-06-30 |
$-16 |
| 2013-03-31 |
$-16 |
| 2012-12-31 |
$-17 |
| 2012-09-30 |
$-17 |
| 2012-06-30 |
$-17 |
| 2012-03-31 |
$-17 |
| 2011-12-31 |
$-19 |
| 2011-09-30 |
$-19 |
| 2011-06-30 |
$-20 |
| 2011-03-31 |
$-21 |
| 2010-12-31 |
$-21 |
| 2010-09-30 |
$-22 |
| 2010-06-30 |
$-23 |
| 2010-03-31 |
$-24 |
| 2009-12-31 |
$-24 |
| 2009-09-30 |
$-25 |
| 2009-06-30 |
$-25 |
| 2009-03-31 |
$-27 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.029B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
